Associated research groups:

Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, Følling I, Tjønnfjord GE (2024)
Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy
Clin Lymphoma Myeloma Leuk (in press)
DOI 10.1016/j.clml.2024.10.005, PubMed 39500643

Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A et al. (2024)
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
Future Oncol, 1-21 (in press)
DOI 10.1080/14796694.2024.2394323, PubMed 39287147

Hamnvik LHD, Eide-Olsen S, Fosseng A, Schjesvold FH (2024)
Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021
Clin Lymphoma Myeloma Leuk (in press)
DOI 10.1016/j.clml.2024.07.015, PubMed 39191633